MEDI:GATE NEWS Toolgen-Bionia, CRISPR Genetic Scissors Technology Transfer Agreement

Toolgen, a genetically corrected company, announced on the 22nd that it has signed a technology transfer contract with Bioneer, a company specializing in the production of reagents and equipment for molecular diagnosis and research.

With this technology transfer, the two companies are planning to launch CRISPR gene scissors specialty brand’AccuTool’ for research in the form of co-branding and enter the CRISPR research market at home and abroad. Toolgen earns royalty revenue based on AccuTool sales.

Bioneer Park Han-oh, CEO of Bioneer said, “Through this contract, Bioneer’s existing CRISPR service has been significantly expanded to launch AccuTool, a professional brand that provides CRISPR/CAS9 total services.” “We are confident that we will become a brand that will lead the global market with our know-how in the product market and Toolgen’s expertise in CRISPR gene shear technology.”

“Through the launch of the AccuTool brand, Toolgen’s CEO Lee Byung-Hwa said, “Through the launch of the AccuTool brand, we are able to supply the CRISPR gene scissors business for research that Toolgen has been promoting with better quality to more customers.” “It will be another example of the platform’s scalability.”